News | April 9, 2019
Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study
Read More
News | March 1, 2019
Genome editing company Precision proposes $100M IPO
Read More
Press Release | January 4, 2019
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Read More
News | January 3, 2019
Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809
Read More
